CTOs on the Move

Tapinator

www.tapinator.com

 
Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tapinator.com
  • 140 West 57th Street; Suite 9C
    New York, NY USA 10019
  • Phone: 914.930.6232

Executives

Name Title Contact Details

Similar Companies

Rocky Mountain Health Care Services

Rocky Mountain PACE is a healthcare organization that provides coordinated health care services for older adults through the PACE model of care (Program of All-Inclusive Care for the Elderly). Their mission is to improve lives, optimize wellness, and p...

Value Drug Company

Value Drug Company, founded in 1934 and incorporated in 1936, is a wholesale purchasing cooperative of Independent Pharmacies.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

MEDWRITE Medical Communications

MEDWRITE Medical Communications is a Maiden Rock, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Field Crest Care Ctr

Field Crest Care Ctr is a Hayfield, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.